Responses
Regular and Young Investigator Award Abstracts
Combination Immunotherapies
885 Characterization of the tumor microenvironment in advanced breast cancer patients treated with talazoparib followed by combination of talazoparib and avelumab
Compose a Response to This Article
Other responses
No responses have been published for this article.
